Medscape
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). Augtyro for Advanced Cancers The regulatory body’s Committee for Medicinal Products for Human Use (CHMP) supported granting a conditional marketing authorization for Augtyro (repotrectinib…
Read More
Two Lung Cancer Drugs Recommended by EMA
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). Augtyro for Advanced Cancers The regulatory body’s Committee for Medicinal Products for Human Use (CHMP) supported granting a conditional marketing authorization for Augtyro (repotrectinib…